lorvotuzumab mertansine antibodydrug conjugate comprises antibody lorvotuzumab maytansinoid cellkilling agent attached using disulfide linker spp attached antibody spp linker mertansine attached thioether linker smcc emtansinecitation needed lorvotuzumab mertansine experimental agent created treatment positive cancers eg smallcell lung cancer ovarian granted orphan drug status merkel cell reported encouraging phase ii results smallcell lung monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikilorvotuzumabmertansine